Lululemon Dog: Activist Battle Shakes Growth Path Ahead
An activist investor is pressing for board seats in a high-stakes proxy battle at Lululemon, highlighting questions a...
Knowing what not to do as a new investor can save you time and money. Avoid common mistakes to build a successful investment portfolio.
28,184 articlesAn activist investor is pressing for board seats in a high-stakes proxy battle at Lululemon, highlighting questions a...
Lionsgate faces a shifting media world where film, TV, and streaming collide. This guide breaks down the 2026 earning...
Mortgage rates have shifted from stubborn highs to a window of lower financing costs. This article shows how investor...
What if the Oracle of Omaha retired having not purchased his beloved stock after decades of bets? This article dives ...
Ripple ETFs post a tepid week of inflows while XRP clings close to $1.40, as traders wrestle with whether the initial...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
SoundHound AI trades in a fast-moving AI landscape with big growth potential and meaningful risks. This piece breaks ...
Altria just posted strongest growth in years, signaling a potential turning point. But behind the headlines lie shift...
JPMorgan Chase just paired a 10% dividend hike with a $50 billion buyback after clearing the Fed's stress test. Here'...
Jeff Bezos-led Blue Origin plans a $10 billion external round at a $130 billion valuation, a move that reframes priva...
Daiwa upgrades Qualcomm to Outperform, increasing the target to $225 as analysts forecast a broader AI infrastructure...
Two popular small-cap ETFs battle for attention: IJR and ISCB. This guide breaks down how they differ, the costs, ris...